Biostatistics And Programming — More Than Just Clinical Trials

A small biotech company had previously conducted three studies on a dermatologic drug, using the collected data solely for the pre-planned endpoints. Years later, they sought to uncover additional insights, such as new objectives or different analytical methods, from their existing data.

The company enlisted ProPharma to ingest and review the legacy data for any meaningful and actionable insights. ProPharma’s biostatisticians and programmers successfully ingested, cleaned, and analyzed the data, ultimately providing the biotech with several interesting and actionable measures.

See how these insights could potentially lead to new label claims and applications for the drug in new subpopulations by downloading the case study below.